# EDGAR Filing Document

**Accession Number:** 0000924383
**File Stem:** 0001193125-26-044673
**Filing Date:** 2026-2
**Character Count:** 19576
**Document Hash:** 32df110023d80c8522863cea60718e38
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-044673.hdr.sgml**: 20260210

**ACCESSION NUMBER**: 0001193125-26-044673

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260210

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260210

**DATE AS OF CHANGE**: 20260210

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Genasys Inc.
- **CENTRAL INDEX KEY:** 0000924383
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOUSEHOLD AUDIO & VIDEO EQUIPMENT [3651]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 870361799
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-24248
- **FILM NUMBER:** 26615964

**BUSINESS ADDRESS:**
- **STREET 1:** 16262 WEST BERNARDO DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127
- **BUSINESS PHONE:** 858-676-1112

**MAIL ADDRESS:**
- **STREET 1:** 16262 WEST BERNARDO DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92127

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LRAD Corp
- **DATE OF NAME CHANGE:** 20100326

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMERICAN TECHNOLOGY CORP /DE/
- **DATE OF NAME CHANGE:** 19940602

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## FORM 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** February 10, 2026<br>

------

Genasys Inc.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 000-24248 | 87-0361799 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 16262 West Bernardo Drive |  |  |
| San Diego**,** California |  | 92127 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** 858 676-1112<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common stock, $0.00001 par value per share | GNSS | NASDAQ Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## Item 2.02 Results of Operations and Financial Condition.
The following information is furnished pursuant to Item 2.02, "Results of Operations and Financial Condition," and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information, including Exhibit 99.1, shall not be incorporated by reference into any filing of Genasys Inc. (the "Company"), whether made before or after the date hereof, regardless of any general incorporation language in such filing.

On February 10, 2026, the Company issued a press release regarding its financial results for the fiscal quarter ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto, and is incorporated by reference herein.

## Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.

---

| | |
|:---|:---|
| Exhibit Number | Description |
| 99.1 | [<u>Financial Results Press Release, dated February 10, 2026, issued by the Company.</u>](gnss-ex99_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | Genasys Inc. |
| Date: | February 10, 2026 | By:  | /s/ Cassandra L. Hernandez-Monteon |
|  |  |  | Cassandra L. Hernandez-Monteon<br>Chief Financial Officer |

---

------

## Exhibit 99.1

**Exhibit 99.1**

![img147471742_0.jpg](img147471742_0.jpg)

**Genasys Reports Fiscal First Quarter 2026 Results**

***Revenue of $17.1M Marks Strong Start to Fiscal 2026***

**SAN DIEGO, CA** – **February 10, 2026** – Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, today announced financial results for the Company's fiscal 2026 first quarter ended December 31, 2025.

**Recent Business Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Delivered $17.1 million in revenue for the fiscal first quarter of 2026, highlighting sustained growth and operational execution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Appointed Cassandra Hernandez-Monteon as Chief Financial Officer, bringing proven internal leadership, deep institutional knowledge, and a strong track record of financial discipline to support Genasys' long-term value creation and strategic execution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Repaid the $4.0 million incremental term loan in full, demonstrating strong cash flow generation and disciplined balance sheet management.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Cash, cash equivalents and marketable securities totaled $10.3 million as of December 31, 2025.

**Management Commentary and Outlook**

"We started fiscal 2026 on a strong note, delivering first quarter revenue of $17.1 million driven by robust execution on the Puerto Rico project and increased sales across our hardware products," said Richard Danforth, Genasys' Chief Executive Officer. "Additionally, during the fiscal first quarter of 2026, we fully repaid the incremental $4.0 million term loan from May 2025 and appointed Cassandra Hernandez-Monteon as Chief Financial Officer. These milestones strengthened the Company's balance sheet and leadership team, reinforcing our financial discipline and positioning us to execute against our strategic priorities with greater flexibility and confidence.

"Looking ahead, Genasys remains well positioned to drive sustained growth and long-term value creation for our shareholders. Large-scale contracts, including the Puerto Rico Dams Early Warning System (EWS) project and the Common Remotely Operated Weapons Station (CROWS) II Technical Refresh program, provide a solid foundation for our backlog as we continue to expand our presence across multiple-end markets.

"Public safety and emergency warning have become increasingly critical in today's environment, creating a growing number of applications for our solutions. As we progress through the fiscal year, we expect to deliver meaningful year-over-year revenue growth with annual gross margin expected to be approximately 50%. This margin profile, paired with continued strong top-line performance, positions us

------

to achieve both operating and net income profitability in fiscal 2026. With a solid backlog and an expanding pipeline, we are confident in our ability to execute effectively, capture additional market share, and return to profitability this fiscal year."

**Fiscal Q1 2026 Financial Summary** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Revenue of $17.1 million, versus $6.9 million in the fiscal 2025 first quarter

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Gross margin of 48.0%, versus 45.8% in the fiscal 2025 first quarter

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•GAAP operating loss of ($0.4) million, versus a GAAP operating loss of ($5.9) million in the fiscal 2025 first quarter

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA of $0.7 million, versus ($4.8) million in the fiscal 2025 first quarter

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•GAAP net loss of ($0.8) million versus ($4.1) million in the fiscal 2025 first quarter. GAAP net loss per share ($0.02) versus ($0.09) in the fiscal 2025 first quarter

**Fiscal Q1 2026 Financial Results**

Fiscal first quarter revenue was $17.1 million, an increase of 145.9% from $6.9 million in the prior year's quarter.

Gross profit margin was 48.0%, compared with 45.8% in the first quarter of fiscal 2025. The increase in gross profit margin was primarily driven by the increase in hardware revenue. Moving forward, we expect margins to expand to roughly 50% for the fiscal year.

Operating expenses decreased 6.4% to $8.5 million from $9.1 million in the fiscal first quarter 2025. Selling, general and administrative expenses decreased 2.8% to $6.6 million from $6.8 million in the quarter ended December 31, 2025. Research and development expenses decreased 17.1% year-over-year to $1.9 million from $2.3 million in the fiscal first quarter 2025.

GAAP net loss in the quarter was ($0.8) million, or ($0.02) per share, compared with a GAAP net loss of ($4.1) million, or ($0.09) per share, in the first quarter of fiscal 2025. The decrease in GAAP net loss was primarily driven by the increase in revenues and reductions in operating expenses.

Adjusted EBITDA was $0.7 million for the first quarter of fiscal 2026, compared with ($4.8) million for the prior fiscal year period.

Cash, cash equivalents and marketable securities totaled $10.3 million as of December 31, 2025, compared to $8.0 million at September 30, 2025. This balance is net of the $4.0 million incremental term loan repayment. Based on current cash position and order backlog, the Company believes they have sufficient capital to service the near- and long-term debt.

\*We include in this press release adjusted EBITDA, which is a non-GAAP financial measure and which we believe provides helpful information to investors with respect to evaluating the Company's performance.

------

Adjusted EBITDA represents our net income (loss) before interest income, interest expense, income tax expense (benefit), depreciation and amortization expense, share-based compensation, fair value measurements of our term loans and warrants, and other items that we do not consider indicative of our core operating performance. Adjusted EBITDA is a measure used by management to understand and evaluate our core operating performance and trends and to generate future operating plans, make strategic decisions regarding allocation of capital and invest in initiatives that are focused on cultivating new markets for our solutions. In particular, the exclusion of certain expenses in calculating adjusted EBITDA facilitates comparisons of our operating performance on a period-to-period basis. However, since adjusted EBITDA is a non-GAAP financial measure, it is not necessarily comparable with adjusted EBITDA used by other companies. Adjusted EBITDA has limitations and should not be considered in isolation or a substitute for performance measures calculated under GAAP, including net income (loss).

**Webcast and Conference Call Details**

Management will host a conference call to discuss the financial results for the fiscal first quarter 2026 this afternoon at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. To access the conference call, dial toll-free (800) 715-9871, or international at +1 (646) 307-1963. A webcast will also be available at the following link: <u>https://app.webinar.net/axb6rY5reog</u>

Questions to management may be submitted before the call by emailing them to: <u>ir@genasys.com</u>. A replay of the webcast will be available approximately four hours after the presentation on the page of the Company's website.

**About Genasys Inc.**

Genasys Inc. (NASDAQ: GNSS) is the global leader in Protective Communications. Incorporating the most comprehensive portfolio of preparedness, response, and analytics software and hardware systems, including the Company's Long Range Acoustic Device® (LRAD®), the Genasys Protect® platform is designed around one premise: ensuring organizations and public safety agencies are *Ready when it matters*®. Protecting people and saving lives for over 40 years, Genasys covers more than 155 million people in all 50 states and in over 100 countries worldwide. For more information, visit <u>genasys.com</u>.

**Forward-Looking Statements**

Except for historical information contained herein, the matters discussed are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these statements. We base these statements on particular assumptions that we have made in light of our industry experience, the stage of product and market development as well as our perception of historical trends, current market conditions, current economic data, expected future developments and other factors that we believe are appropriate under the circumstances. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in any forward-looking statement. The risks and

------

uncertainties in these forward-looking statements include without limitation risks relating to receiving timely payment under, regulatory uncertainties surrounding, or disruptions in governmental support or funding of, the Puerto Rico project, our reliance on a limited number of customers, the likely need for additional capital, actual or perceived failures or breaches of our information and security systems, continued funding of government spending, the timing of such funding, general economic and business conditions, including unforeseen weakness in the Company's markets, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, market acceptance of the Company's products, shortages in components or price increases that cannot be passed on to customers, inability to fully realize the expected benefits from acquisitions and restructurings or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, changes to export regulations, difficulties in retaining key employees and customers, changes in the market for microcap stocks regardless of growth and value and various other factors beyond our control. Risks and uncertainties are identified and discussed in our filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. For more information regarding potential risks and uncertainties, see the "Risk Factors" section of the Company's Form 10-K for the fiscal year ended September 30, 2025. Genasys Inc. disclaims any intent or obligation to publicly update or revise forward-looking statements, except as otherwise specifically stated.

**Investor Contact**

Scott Liolios and Clay Liolios<br>Gateway Group, Inc. <br>949-574-3860<br><u>GNSS@gateway-grp.com</u>

------

**Genasys Inc.**

**Consolidated Balance Sheet**

**(Unaudited - in thousands)**

---

| | | |
|:---|:---|:---|
|  | **December 31,<br>2025** | **September 30,<br>2025** |
|  | **(Unaudited)** |  |
| **ASSETS** |  |  |
| **Current assets:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $10286 | $7969 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term marketable securities | 30 | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 8882 | 7596 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract assets | 7150 | 6117 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 8573 | 8805 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other | 9079 | 8742 |
| **Total current assets** | 44000 | 39299 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term restricted cash | 585 | 585 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | 1020 | 1125 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 13451 | 13450 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 5570 | 6147 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right of use assets, net | 2214 | 2419 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 806 | 844 |
| **Total assets** | $67646 | $63869 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| **Current liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $7463 | $8181 |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer deposit | 30305 | 19669 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 7276 | 7451 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities, current portion | 1145 | 1125 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable, at fair value | 13820 | 18010 |
| **Total current liabilities** | 60009 | 54436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Warrant liability | 2700 | 3570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term deferred revenue | 1209 | 1478 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities, noncurrent | 1922 | 2218 |
| **Total liabilities** | 65840 | 61702 |
| **Total stockholders' equity** | 1806 | 2167 |
| **Total liabilities and stockholders' equity** | $67646 | $63869 |

---

------

**Genasys Inc.**

**Consolidated Statements of Operations**

**(Unaudited - in thousands, except per share amounts)**

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** |
|  | **2025** | **2024** |
|  | **(unaudited)** | **(unaudited)** |
| **Revenues** | $17065 | $6940 |
| **Cost of revenues** | 8882 | 3762 |
| **Gross profit** | 8183 | 3178 |
|  | 48.0% | 45.8% |
| **Operating expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 6640 | 6834 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 1895 | 2285 |
| Total operating expenses | 8535 | 9119 |
| Loss from operations | (352) | (5941) |
| Other expenses (income), net | (340) | 1863 |
| Loss before income taxes | (692) | (4078) |
| Income tax expense | 125 |  |
| **Net loss** | $(817) | $(4078) |
| **Net loss per common share - basic and diluted** | $(0.02) | $(0.09) |
| **Weighted average common shares outstanding - basic and diluted** | 45197 | 44912 |
| **Reconciliation of GAAP measures to non-GAAP measures** |  |  |
| Net loss | $(817) | $(4078) |
| Other expenses (income), net | 340 | (1863) |
| Income tax expense | 125 |  |
| Depreciation and amortization | 682 | 737 |
| Share based compensation | 419 | 391 |
| **Adjusted EBITDA** | $749 | $(4813) |

---

------